COVID-19 Drug Nirmatrelvir/Ritonavir Expected To Hit Private Market In Mid-2023

Kaiser Health News (12/7, Recht) reports that “nearly 6 million Americans have taken” nirmatrelvir/ritonavir (Paxlovid) “for free, courtesy of the federal government.” However, “the government plans to stop footing the bill within months, and millions of...